A coronary artery calcium (CAC) score of 0 misses early non-calcified plaque in young adults, so CAC is insensitive for early atherosclerosis detection in this population
Summary
CAC measures calcified plaque only; coronary atherosclerosis begins as non-calcified (fibrofatty/lipid-rich) plaque that calcifies years later. Multiple imaging studies (PESA, CCTA cohorts, IVUS series) show that young adults with documented non-calcified plaque frequently have CAC=0. In the PESA cohort of middle-aged adults, roughly half of those with subclinical atherosclerosis on vascular ultrasound or CCTA had CAC=0. Sensitivity of CAC for any plaque is particularly low (~40-60%) in adults under 50. Major guidelines (ACC/AHA 2018 cholesterol, 2019 primary prevention) still endorse CAC for risk reclassification in intermediate-risk adults ≥40, acknowledging its limitation in younger populations where CCTA or other modalities may be preferred.
Five-score assessment
Scope
- Adults >55 years (CAC retains high negative predictive value)
- Risk stratification in asymptomatic intermediate-risk adults per ACC/AHA guidelines (CAC=0 remains a useful de-risking tool in that population)
- Claims that CAC is useless overall — it is validated for risk reclassification in middle-aged/older adults
Evidence sources
Supporting (4)
-
trial_registry Fernández-Friera et al., PESA study, Circulation 2015 ↗In 4,184 middle-aged asymptomatic adults, non-calcified subclinical atherosclerosis was present in many participants with CAC=0, demonstrating CAC underestimates early plaque burden.
-
Meta-analysis showed non-calcified plaque on CCTA in patients with CAC=0 carries incremental prognostic information, confirming CAC misses non-calcified disease.
-
Review confirms the 'power of zero' CAC weakens in adults <45 and in high-risk groups where non-calcified plaque predominates.
-
Young FH patients with CAC=0 still showed significant non-calcified plaque on CCTA and elevated event rates, supporting CAC insensitivity in this population.
Neutral / context (1)
-
Endorses CAC for risk reclassification in intermediate-risk adults ≥40 but notes CAC=0 does not exclude non-calcified plaque, especially in younger adults and those with familial hypercholesterolemia.